Zelda Therapeutics Ltd (ASX:ZLD) has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) relating to the pharmacology of cannabinoids . The ultimate goal is to describe cannabinoid disposition in pediatric patients, and identify compounds that may demonstrate efficacy … Read More
The post Zelda Therapeutics and Children’s Hospital of Philadelphia to study the pharmacology of … appeared first on Dagga Magazine.